Skip to main content
. 2024 Dec 11;17:6053–6064. doi: 10.2147/IJGM.S485079

Table 7.

Comparison of Concomitant Diseases

Concomitant diseases Ulcerative Colitis(%) N=454 Crohn’s Disease(%) N=333 p value
Yes 393(86.6%) 265(79.6%) 0.009
With two or more 333(73.3%) 196(58.9%) <0.001
Rheumatic diseases 8(1.8%) 19(5.7%) 0.003
Hypertension 108(23.8%) 49(14.7%) 0.002
Pulmonary nodules 28(6.2%) 14(4.2%) 0.226
Cerebral infarction 23(5.1%) 12(3.6%) 0.325
Diabetes 35(7.7%) 14(4.2%) 0.044
Hyperlipidemia 12(2.6%) 8(2.4%) 0.832
Osteoporosis 27(5.9%) 25(7.5%) 0.384
Thyroid dysfunction 14(3.1%) 6(1.8%) 0.259
Colorectal polyps 95(20.9%) 27(8.1%) <0.001
Reflux esophagitis 48(10.6%) 17(5.1%) 0.006
Peptic ulcer 34(7.5%) 30(9.0%) 0.441
Fatty liver 70(15.4%) 43(12.9%) 0.322
Autoimmune liver disease 0(0.0%) 1(0.3%) 0.423
Old pulmonary tuberculosis 20(4.4%) 7(2.1%) 0.079
Hepatitis B 9(2.0%) 9(2.7%) 0.504
EB virus infection 7(1.5%) 23(6.9%) <0.001
T-SPOT positive 5(1.1%) 5(1.5%) 0.750
Upper gastrointestinal cancers 1(0.2%) 2(0.6%) 0.787
Colorectal cancer 9(2.0%) 1(0.3%) 0.051
Other tumors 18(4.0%) 16(4.8%) 0.567